Document Detail


Factor V (Arg 506-->Gln) mutation in young survivors of myocardial infarction.
MedLine Citation:
PMID:  8725707     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Many young patients with venous thromboembolic disease are partially resistant to the anticoagulant action of activated protein C as a result of factor V (Arg 506 --> Gln) mutation. The frequency of this mutation in young patients with arterial thrombotic diseases, such as myocardial infarction, is less well established. We studied 100 young patients with myocardial infarction and 100 age- and sex-matched controls. One patient (1%; 95% CL 0.05-6.2) and two controls (2%; 95% CL 0.3-7.7) were heterozygotes for the mutation; there was no homozygote in either group. Hence, premature myocardial infarction is not associated with heterozygosity for factor V (Arg 506 --> Gln) mutation.
Authors:
D Ardissino; F Peyvandi; P A Merlini; E Colombi; P M Mannucci
Related Documents :
4885307 - Assessment of short-anticoagulant administration after cardiac infarction. report of th...
15586627 - Clinical potential of oral direct thrombin inhibitors in the prevention and treatment o...
7746397 - Early anticoagulation after large cerebral embolic infarction: a safety study.
9538317 - Left atrial thrombus as an early consequence of blunt chest trauma.
19915847 - Aortic stiffness is associated with cardiac function and cerebral small vessel disease ...
8250297 - Protamine and left ventricular function: a transesophageal echocardiography study.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Thrombosis and haemostasis     Volume:  75     ISSN:  0340-6245     ISO Abbreviation:  Thromb. Haemost.     Publication Date:  1996 May 
Date Detail:
Created Date:  1997-01-21     Completed Date:  1997-01-21     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7608063     Medline TA:  Thromb Haemost     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  701-2     Citation Subset:  IM    
Affiliation:
Division of Cardiology, I.R.C.C.S., Policlinico San Matteo, Pavia, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Age Factors
Arginine / genetics
Case-Control Studies
Factor V / genetics*
Female
Heterozygote
Homozygote
Humans
Male
Myocardial Infarction / blood,  genetics*
Point Mutation
Chemical
Reg. No./Substance:
74-79-3/Arginine; 9001-24-5/Factor V

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Noncontraceptive benefits and therapeutic uses of depot medroxyprogesterone acetate.
Next Document:  Heightened thrombin generation in individuals with resistance to activated protein C.